42684 Federal Register / Vol. 82, No. 174 / Monday, September 11, 2017 / Notices 

1For purposes of this proposal, the FIRREA 

agencies consist of: The Federal Reserve Board, the 

Office of the Comptroller of the Currency, the 

Federal Deposit Insurance Corporation, the National 

Credit Union Administration, the Commodities 

Futures Trading Commission, the Farm Credit 

Administration, and the Securities and Exchange 

Commission. 

of 1989 (FIRREA) agencies 1 conduct the 

FR 29a survey jointly. The FR 29b is 

collected by the Board only. 

Legal authorization and 

confidentiality: The Board’s Legal 

Division has determined that the FR 29a 

and FR29b surveys are voluntary and 

authorized by sections 10(4) and 11(1) 

of the Federal Reserve Act (12 U.S.C. 

244 and 248(1)), which authorize the 

Board to determine employees’ 

compensation. The FR 29a survey is 

completed by an outside consultant that 

submits to the Board a report of the 

survey containing only aggregate data. 

Because the Board does not collect or 

have access to the individual 

respondent data, no confidentiality 

issue arises with respect to the 

individual responses to the FR 29a. The 

Board does not consider the report 

containing aggregate data to be 

confidential. The FR 29b consists of ad 

hoc surveys conducted by the Board 

during the year to collect information on 

specific salary and non-salary matters 

that affect Board employees. The ability 

of the Board to maintain the 

confidentiality of information provided 

by respondents to the FR 29b surveys 

will have to be determined on a case by 

case basis depending on the data 

collected under a particular survey. 

Some of the information collected on 

the surveys may be protected from 

Freedom of Information Act (FOIA) 

disclosure by FOIA exemptions 4 and 6. 

(5 U.S.C. 552 (b)(4) and (6)). Exemption 

4 protects from disclosure trade secrets 

and commercial or financial 

information, while Exemption 6 protects 

information ‘‘the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.’’ 

Consultation outside the agency: 

Towers Watson and the Board work 

together to review and update the FR 

29a survey instrument. 

Current actions: On June 29, 2017 the 

Board published a notice in the Federal 

Register (82 FR 29564) requesting 

public comment for 60 days on the 

extension, without revision, of the 

Compensation and Salary Surveys. The 

comment period for this notice expired 

on August 28, 2017. The Board did not 

receive any comments. 

Board of Governors of the Federal Reserve 

System, September 6, 2017. 

Ann E. Misback, 

Secretary of the Board. 

[FR Doc. 2017–19168 Filed 9–8–17; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RETIREMENT THRIFT 

INVESTMENT BOARD 

Sunshine Act; Notice of Board Member 

Meeting: Federal Retirement Thrift 

Investment Board 

AGENDA: Federal Retirement Thrift 

Investment Board Members’ Meeting, 

September 18, 2017, 8:30 a.m. (InPerson). 

Open Session 

1. Approval of the Minutes of the 

August 28, 2017 Board Members’ 

Meeting 

2. Monthly Reports 

(a) Participant Activity Report 

(b) Investment Performance Report 

(c) Legislative Report 

3. Calendar Review 2017/2018 

4. FY 18 Budget Review and Approval 

5. Vendor Financials 

6. The Office of Participant Services’ 

Annual Report 

7. Blended Retirement Update 

8. IT Update 

Closed Session 

Information covered under 5 U.S.C. 

552b(c)(4) and (c)(9)(B). 

CONTACT PERSON FOR MORE INFORMATION: 

Kimberly Weaver, Director, Office of 

External Affairs, (202) 942–1640. 

Dated: September 7, 2017. 

Megan Grumbine, 

General Counsel, Federal Retirement Thrift 

Investment Board. 

[FR Doc. 2017–19268 Filed 9–7–17; 4:15 pm] 

BILLING CODE 6760–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Community Preventive 

Services Task Force (Task Force) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) within 

the Department of Health and Human 

Services announces the next meeting of 

the Community Preventive Services 

Task Force (Task Force) on October 18– 

19, 2017 in Atlanta, Georgia. 

DATES: The meeting will be held on 

Wednesday, October 18, 2017 from 8:30 

a.m. to 6:00 p.m. EDT and Thursday, 

October 19, 2017 from 8:30 a.m. to 1:00 

p.m. EDT. 

ADDRESSES: The Task Force Meeting 

will be held at the CDC Edward R. 

Roybal Campus, Centers for Disease 

Control and Prevention Headquarters 

(Building 19), 1600 Clifton Road NE., 

Atlanta, GA 30329. You should be 

aware that the meeting location is in a 

Federal government building; therefore, 

Federal security measures are 

applicable. For additional information, 

please see Roybal Campus Security 

Guidelines under SUPPLEMENTARY

INFORMATION. Information regarding 

meeting logistics will be available on 

the Community Guide Web site 

(www.thecommunityguide.org) closer to 

the date of the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Onslow Smith, Center for Surveillance, 

Epidemiology and Laboratory Services; 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

E–69, Atlanta, GA 30329, phone: (404) 

498–6778, email: CPSTF@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Meeting accessibility: This spacelimited meeting is open to the public. 

All meeting attendees must register. To 

ensure completion of required security 

procedures and access to the CDC’s 

Global Communications Center, U.S. 

citizens intending to attend in person 

must register by October 11, 2017. NonU.S. citizens intending to attend in 

person must register by September 20, 

2017. Failure to register by the dates 

identified could result in the inability to 

attend the Task Force meeting in 

person. 

Those unable to attend the meeting in 

person are able to do so via Webcast. 

CDC will send the Webcast URL to 

registrants upon receipt of their 

registration. All meeting attendees must 

register by October 13, 2017 to receive 

the webcast information. CDC will email 

webcast information from the CPSTF@

cdc.gov mailbox. 

Public comment: A public comment 

period, limited to three minutes per 

person, will follow the Task Force’s 

discussion of each systematic review. 

Individuals wishing to make public 

comments must indicate their desire to 

do so with their registration by 

providing their name, organizational 

affiliation, and the topic to be addressed 

(if known). Public comments will 

become part of the meeting summary. 

Public comment is not possible via 

Webcast. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 174 / Monday, September 11, 2017 / Notices 42685 

Background on the Task Force: The 

Task Force is an independent, 

nonfederal panel whose members are 

appointed by the CDC Director. Task 

Force members represent a broad range 

of research, practice, and policy 

expertise in prevention, wellness, health 

promotion, and public health. The Task 

Force was convened in 1996 by the 

Department of Health and Human 

Services (HHS) to identify community 

preventive programs, services, and 

policies that increase healthy longevity, 

save lives and dollars, and improve 

Americans’ quality of life. CDC is 

mandated to provide ongoing 

administrative, research, and technical 

support for the operations of the Task 

Force. During its meetings, the Task 

Force considers the findings of 

systematic reviews on existing research 

and practice-based evidence and issues 

recommendations. Task Force 

recommendations are not mandates for 

compliance or spending. Instead, they 

provide information about evidencebased options that decision makers and 

stakeholders can consider when they are 

determining what best meet the specific 

needs, preferences, available resources, 

and constraints of their jurisdictions 

and constituents. The Task Force’s 

recommendations, along with the 

systematic reviews of the evidence on 

which they are based, are compiled in 

the Guide to Community Preventive 

Services (The Community Guide). 

Matters proposed for discussion: 

Cardiovascular Disease Prevention 

(Mobile Health Interventions for 

Cardiovascular Disease Prevention); 

Diabetes Prevention and Control 

(Lifestyle Interventions to Reduce Risk 

of Gestational Diabetes); Nutrition 

(Gardening-Based Interventions to 

Increase Fruit and Vegetable Intake); 

Obesity Prevention and Control (Schoolbased Diet and Physical Activity 

Interventions); and Women’s Health 

(Primary Prevention of Intimate Partner 

Violence and Sexual Violence Among 

Youth). The agenda is subject to change 

without notice. 

Roybal Campus Security Guidelines: 

The Edward R. Roybal Campus is the 

headquarters of the CDC and is located 

at 1600 Clifton Road NE., Atlanta, 

Georgia. The meeting is being held in a 

Federal government building; therefore, 

Federal security measures are 

applicable. 

All meeting attendees must register by 

the dates outlined under Meeting 

Accessability. In planning your arrival 

time, please take into account the need 

to park and clear security. All visitors 

must enter the Edward R. Roybal 

Campus through the front entrance on 

Clifton Road. Vehicles may be searched, 

and the guard force will then direct 

visitors to the designated parking area. 

Upon arrival at the facility, visitors must 

present government-issued photo 

identification (e.g., a valid federal 

identification badge, state driver’s 

license, state non-driver’s identification 

card, or passport). Non-U.S. citizens 

must complete the required security 

paperwork prior to the meeting date and 

must present a valid passport, visa, 

Permanent Resident Card, or other type 

of work authorization document upon 

arrival at the facility. All persons 

entering the building must pass through 

a metal detector. CDC Security 

personnel will issue a visitor’s ID badge 

at the entrance to Building 19. Visitors 

may receive an escort to the meeting 

room. All items brought to HHS/CDC 

are subject to inspection. 

Dated: September 6, 2017. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2017–19203 Filed 9–8–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2017–N–4851] 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the Vaccines and Related 

Biological Products Advisory 

Committee (VRBPAC). The general 

function of the committee is to provide 

advice and recommendations to the 

Agency on FDA’s regulatory issues. The 

meeting will be open to the public. 

Members will participate via 

teleconference. 

DATES: The meeting will be held on 

October 4, 2017, from 1 p.m. to 4:30 

p.m. 

ADDRESSES: FDA White Oak Campus, 

10903 New Hampshire Ave., Bldg. 31 

Conference Center, the Great Room (Rm. 

1503), Silver Spring, MD 20993–0002. 

For those unable to attend in person, the 

meeting will also be webcast and will be 

available at the following link: https:// 

collaboration.fda.gov/cbervrbpac2017. 

Answers to commonly asked questions 

including information regarding special 

accommodations due to a disability, 

visitor parking, and transportation may 

be accessed at: https://www.fda.gov/ 

AdvisoryCommittees/ 

AboutAdvisoryCommittees/ 

ucm408555.htm. 

FOR FURTHER INFORMATION CONTACT: 

Serina Hunter-Thomas or Rosanna 

Harvey, Center for Biologics Evaluation 

and Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 71, Rm. 6307C, Silver 

Spring, MD 20993–0002, 240–402–5771 

serina.hunter-thomas@fda.hhs.gov and 

240–402–8072, rosanna.harvey@

fda.hhs.gov, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area). A notice in the 

Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

Agency’s Web site at https://

www.fda.gov/AdvisoryCommittees/ 

default.htm and scroll down to the 

appropriate advisory committee meeting 

link, or call the advisory committee 

information line to learn about possible 

modifications before coming to the 

meeting. 

SUPPLEMENTARY INFORMATION: 

Agenda: On October 4, 2017, the 

VRBPAC will meet in an open session 

to discuss and make recommendations 

on the selection of strains to be included 

in an influenza virus vaccine for the 

2018 southern hemisphere influenza 

season. FDA intends to make 

background material available to the 

public no later than 2 business days 

before the meeting. If FDA is unable to 

post the background material on its Web 

site prior to the meeting, the background 

material will be made publicly available 

at the location of the advisory 

committee meeting, and the background 

material will be posted on FDA’s Web 

site after the meeting. Background 

material is available at https://

www.fda.gov/AdvisoryCommittees/ 

Calendar/default.htm. Scroll down to 

the appropriate advisory committee 

meeting link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before September 27, 2017. 

Oral presentations from the public will 

be scheduled between approximately 

1:15 p.m. and 2:15 p.m. Those 

individuals interested in making formal 

oral presentations should notify the 

contact person and submit a brief 


asabaliauskas on DSKBBXCHB2PROD with NOTICES